Central Square Foundation

Nonprofit Technology

VolunteerNow | May 11, 2022

The 2022 Texas Volunteer Management Conference (TVMC), powered by VolunteerNow, will be held virtually on June 2-3, 2022. The conference's theme, "Brave New World: Leaning into Challenges," will explore the challenges of reengaging volunteers in a post-COVID-19 world. The two-day national conference includes 20 breakout sessions, a keynote presentation, two plenaries and three networking opportunities for volunteer management professionals. Volu...

Consumers Energy Foundation | March 19, 2020

The Consumers Energy Foundation is supporting two statewide organizations with a $500,000 contribution to help enhance critical services for Michigan children, vulnerable seniors and those who may need assistance in the wake of the COVID-19 pandemic. "For many, the coronavirus pandemic is more than just a disruption to daily life. Families with kids who are food insecure, the elderly and those who live paycheck to paycheck are especially vulnerable. With schools and businesses closed and ma...

Nonprofit Technology

Washington Technology Industry Association | May 21, 2022

Washington Technology Industry Association (WTIA), a non-profit organization dedicated to fostering a robust, equity-centered technology sector that empowers thriving communities, announced sea.citi, a tech industry nonprofit that promotes civic engagement and builds relationships between community, government and innovation workers, has merged with the organization. sea.citi will retain its brand and mission, and be governed by a WTIA steering committee that will initially consist of current se...

GSK | January 27, 2020

GlaxoSmithKline has licensed a tuberculosis vaccine to the Bill & Melinda Gates Medical Research Institute (MRI). The deal sets the stage for a push to build on recent phase 2b data and make the vaccine available in low-income countries where TB is prevalent. The vaccine, M72/AS01E, is made up of an immunogenic fusion protein based on two TB antigens. GSK combined that protein with the adjuvant found in its shingles prophylactic Shingrix to create a subunit vaccine. Last year, a phase 2b tri...